Mingming Wu

1.3k total citations
40 papers, 935 citations indexed

About

Mingming Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mingming Wu has authored 40 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Mingming Wu's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (5 papers). Mingming Wu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (5 papers). Mingming Wu collaborates with scholars based in China, Singapore and United States. Mingming Wu's co-authors include Tao Zhu, Peter E. Lobie, Weijie Zhang, Xiao Zhang, Pengxu Qian, Sheng Tan, Xinghua Han, Wenchang Qian, Yue Shen and Yun Zhang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mingming Wu

34 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingming Wu China 18 526 327 122 113 109 40 935
Yulian Wu China 19 410 0.8× 158 0.5× 173 1.4× 186 1.6× 68 0.6× 42 843
Yuxuan Li China 16 800 1.5× 189 0.6× 54 0.4× 172 1.5× 90 0.8× 53 1.1k
Jiani Huang China 16 507 1.0× 196 0.6× 161 1.3× 84 0.7× 132 1.2× 28 1.0k
Yifan Cai China 18 357 0.7× 127 0.4× 88 0.7× 94 0.8× 110 1.0× 64 950
Ashish Choudhary India 15 500 1.0× 332 1.0× 194 1.6× 51 0.5× 112 1.0× 54 931
Yue-Xiang Chen China 18 511 1.0× 266 0.8× 387 3.2× 107 0.9× 90 0.8× 36 1.3k
Jianbo Pan China 18 534 1.0× 117 0.4× 89 0.7× 93 0.8× 83 0.8× 53 1.3k
Zhendong Zheng China 19 377 0.7× 184 0.6× 203 1.7× 47 0.4× 137 1.3× 82 867

Countries citing papers authored by Mingming Wu

Since Specialization
Citations

This map shows the geographic impact of Mingming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Wu more than expected).

Fields of papers citing papers by Mingming Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Wu. The network helps show where Mingming Wu may publish in the future.

Co-authorship network of co-authors of Mingming Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingming Wu. A scholar is included among the top collaborators of Mingming Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingming Wu. Mingming Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Cao, Ting, Le Huang, Mingming Wu, et al.. (2025). Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4. Frontiers in Cell and Developmental Biology. 13. 1563353–1563353. 2 indexed citations
4.
Wu, Mingming, Shangfeng Yang, Zhentao Yang, et al.. (2025). Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors. Immunity. 58(11). 2864–2877.e9.
5.
Wu, Mingming, Xiao Zhang, Huafeng Zhang, et al.. (2024). Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion. Cancer Research. 84(8). 1270–1285. 36 indexed citations
6.
Wang, Miaomiao, Wang Ya, Yong Zhu, et al.. (2024). LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance. Oncogene. 43(17). 1249–1262. 5 indexed citations
7.
Wang, Yan, Beibei Huang, Mingming Wu, et al.. (2024). Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia. Cell Reports Medicine. 5(6). 101580–101580. 9 indexed citations
8.
Wang, Yan, et al.. (2024). Protocol to measure cell avidity between cord blood-derived NK cells and leukemia cell line KG-1a. STAR Protocols. 5(4). 103387–103387.
9.
Zhang, Xiao, Mingming Wu, Jose Espejo Valle-Inclán, et al.. (2024). The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance. Cell. 187(21). 6055–6070.e22. 22 indexed citations
10.
Wu, Mingming, Lan Mi, Hongjie Yu, et al.. (2023). The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Janus kinase 1 (JAK1) inhibitor AZD4205 on Peripheral T cell lymphoma. Hematological Oncology. 41(S2). 558–559. 1 indexed citations
11.
12.
Wang, Ping, Tingting Liang, Mingming Zhu, et al.. (2023). Unique metabolism and protein expression signature in human decidual NK cells. Frontiers in Immunology. 14. 1136652–1136652. 7 indexed citations
13.
Zhao, Junsong, Junchao Xu, Mingming Wu, et al.. (2023). LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2. International Journal of Molecular Sciences. 24(11). 9157–9157. 12 indexed citations
14.
Wu, Mingming, Xiao Zhang, Weijie Zhang, et al.. (2022). Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nature Communications. 13(1). 1371–1371. 107 indexed citations
15.
Guo, Chuang, Mingming Wu, Beibei Huang, et al.. (2022). Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19. Genome Medicine. 14(1). 46–46. 34 indexed citations
16.
Qian, Wenchang, Yong Zhu, Mingming Wu, et al.. (2020). Linc00668 Promotes Invasion and Stem Cell-Like Properties of Breast Cancer Cells by Interaction With SND1. Frontiers in Oncology. 10. 88–88. 16 indexed citations
17.
Zhang, Weijie, Mingming Wu, Qing-Yun Chong, et al.. (2018). Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer. Cancer Research. 78(17). 4915–4928. 25 indexed citations
18.
Wei, Caihong, Mingming Wu, Chuduan Wang, et al.. (2018). Long Noncoding RNA Lnc-SEMT Modulates IGF2 Expression by Sponging miR-125b to Promote Sheep Muscle Development and Growth. Cellular Physiology and Biochemistry. 49(2). 447–462. 35 indexed citations
19.
Ahmad, Akhlaq, Weijie Zhang, Mingming Wu, Sheng Tan, & Tao Zhu. (2017). Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes. Genes & Genomics. 40(3). 243–251. 48 indexed citations
20.
Wu, Mingming, Na Ye, Biswa Sengupta, & Harold H. Zakon. (2013). A naturally occurring amino acid substitution in the voltage-dependent sodium channel selectivity filter affects channel gating. Journal of Comparative Physiology A. 199(10). 829–842. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulian Wu Breakdown of academic impact, for papers by Yuxuan Li Breakdown of academic impact, for papers by Jiani Huang Breakdown of academic impact, for papers by Yifan Cai Breakdown of academic impact, for papers by Ashish Choudhary Breakdown of academic impact, for papers by Yue-Xiang Chen Breakdown of academic impact, for papers by Jianbo Pan Breakdown of academic impact, for papers by Zhendong Zheng
Rankless by CCL
2026